Varicocele Repair for Men Undergoing IVF/ICSI
Varicocele
Varicocele Repair for Infertile Men Undergoing IVF/ICSI: a Parallel, Two-group, Randomized Trial
1 other identifier
interventional
2,000
0 countries
N/A
Brief Summary
For infertile men undergoing intracytoplasmic sperm injection (ICSI), data from retrospective studies suggested that varicocele repair may be beneficial and associated with improved livebirth and pregnancy rates, however, its role remains uncertain and disputed. To date, the investigators are not aware of published randomized controlled trail (RCT) that have evaluated whether varicocele repair would improve ICSI outcomes on patients with male-factor infertility.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2020
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 11, 2020
CompletedFirst Posted
Study publicly available on registry
October 29, 2020
CompletedStudy Start
First participant enrolled
December 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedOctober 29, 2020
October 1, 2020
2 years
October 11, 2020
October 28, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Livebirth rate
the percentage of women who underwent randomization and will have a livebirth after at least 37 completed weeks of gestation
up to 37 weeks
Secondary Outcomes (10)
Biochemical pregnancy
up to 2 weeks
Clinical pregnancy
up to 7 weeks
Ongoing pregnancy
up to 20 weeks
Miscarriage
up to 20th weeks
stillbirth
up to 20 weeks
- +5 more secondary outcomes
Study Arms (2)
varicocelectomy arm
EXPERIMENTALThe varicocelectomy procedure will be performed three months before ICSI for men with with male-factor infertility and were diagnosed clinically with varicocele
Control (No varicocelectomy) arm
NO INTERVENTIONCouples with male-factor infertility and males were diagnosed clinically with varicocele will undergo ICSI
Interventions
microsurgical subinguinal varicocelectomy
Eligibility Criteria
You may qualify if:
- Couples able to provide informed consent.
- Couples with at least 12 months of infertility
- Couples with male-factor infertility
- Couples counseled for ICSI procedure by reproductive specialist.
- Couples undergoing their first ICSI cycle or their second ICSI cycle after a previously successful treatment.
- Female: age between 18-43; body mass index (BMI) between 19.0-35.0 kg/m2; FSH level 3.0-20.0 miU/mL and/or AMH ≥1.5 pmol/L; with regular menstrual cycles (defined as 25 to 35 days in duration), evidence of ovulation (by biphasic basal body temperature, ovulation predictor kits, or luteal serum progesterone level ≥3 ng/mL), have no uterine abnormality by ultrasound; anticipated normal responder (≥5 antral follicle count or ≥5.4 pmol/L Anti- mullerian hormone (AMH).
- Male: age: 18-55; able to produce freshly ejaculated sperm for the treatment cycle; diagnosed with clearly palpable varicocele; have at least one abnormal semen parameter on a semen analysis in the preceding 3 months: sperm concentration ≤15 million/mL (oligospermia), total motility≤40% (asthenospermia), or normal morphology ≤4% (teratospermia); normal hormonal profile
You may not qualify if:
- Patients who willing to undergo ICSI with preimplantation genetic diagnosis.
- Female: have previous two cycles of implantation failure at fresh transfer; with unilateral oophorectomy; PCOs; have any uterine pathology (myomas, adenomyosis, endocrinopathies, thrombophilia, chronic pathologies, acquired or congenital uterine abnormalities); have severe endometriosis; have uni- or bilateral hydrosalpinx; have history of recurrent pregnancy loss, takes any medical condition that affect fertility.
- Male: have varicocele associated with hydrocele or inguinal hernia; secondary and recurrent varicocele, varicocele complicated by thrombophlebitis; varicocele with infertility due to other causes (demonstrated by andrologists), if they have a sperm concentration \<1 million/mL on the screening semen analysis or if they were taking fertility medication or testosterone. Men are required to refrain from taking any medications for 4 weeks before randomization.
- Abnormal karyotyping for female or male partners.
- Uncontrolled diabetes, liver or renal disease, history of malignancy or borderline pathology of male or female partners.
- Previous participation in the trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Al-Yasmeen Fertility and Gynecology Centerlead
- Elite Fertility and Gynecology Center, Cairo, Egyptcollaborator
- Banon IVF Center Assiut, Egyptcollaborator
- IbnSina IVF Center, Sohag, Egyptcollaborator
- Qena IVF Centre, Qena, Egyptcollaborator
- Amshaj IVF Centercollaborator
Related Publications (3)
Kohn TP, Kohn JR, Pastuszak AW. Varicocelectomy before assisted reproductive technology: are outcomes improved? Fertil Steril. 2017 Sep;108(3):385-391. doi: 10.1016/j.fertnstert.2017.06.033.
PMID: 28865536RESULTKirby EW, Wiener LE, Rajanahally S, Crowell K, Coward RM. Undergoing varicocele repair before assisted reproduction improves pregnancy rate and live birth rate in azoospermic and oligospermic men with a varicocele: a systematic review and meta-analysis. Fertil Steril. 2016 Nov;106(6):1338-1343. doi: 10.1016/j.fertnstert.2016.07.1093. Epub 2016 Aug 12.
PMID: 27526630RESULTPractice Committee of the American Society for Reproductive Medicine; Society for Male Reproduction and Urology. Report on varicocele and infertility: a committee opinion. Fertil Steril. 2014 Dec;102(6):1556-60. doi: 10.1016/j.fertnstert.2014.10.007. Epub 2014 Nov 25.
PMID: 25458620RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mohamed Fawzy, Ph.D
IbnSina IVF Center, IbnSina Hospital, Sohag
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 11, 2020
First Posted
October 29, 2020
Study Start
December 1, 2020
Primary Completion
December 1, 2022
Study Completion
August 1, 2023
Last Updated
October 29, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- 3-6 months